0078-0965 : Gilenya .25 mg Oral Capsule
NDC: | 0078-0965 |
Labeler: | Novartis Pharmaceuticals Corporation |
Product Type: | Human Prescription Drug |
Drug Name: | Gilenya |
Dosage Form: | Oral Capsule |
Application #: | NDA022527 |
Rev. Date: |
Appearance:
Markings: | FTY;0;25;mg |
Shapes: |
Capsule |
Colors: |
White |
Size (mm): | 16 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 0078-0965-89: 7 CAPSULE IN 1 CARTON (0078‑0965‑89)
Active Ingredients:
- Fingolimod Hydrochloride
Dosage Strength:
- .25 mg
Inactive Ingredients:
- Gelatin
- Magnesium Stearate
- Mannitol
- Titanium Dioxide
- Hydroxypropyl Cellulose, Unspecified
- Adrabetadex
- Ferric Oxide Yellow /
Pharmaceutical Classes:
- Sphingosine 1-Phosphate Receptor Modulators [MoA]
- Sphingosine 1-phosphate Receptor Modulator [EPC]
Related Products:
Based on records with the same trade name.- 0078-0607 Gilenya 0.5 mg Oral Capsule by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0078-0958Next: 0078-0972 >
Related Discussions:
Gilenya - Fingolimod does it trigger Depression?
I am on day 10 just started Gilenya with 6 other MS people. The first 5 days were fine then fatigue started big time sle... 11 replies
I am on day 10 just started Gilenya with 6 other MS people. The first 5 days were fine then fatigue started big time sle... 11 replies
starting Gilenya have some questions
I will be starting Gilenya in May. I have a 3 month washout period from Tysabri. I will be on Copaxone for 2 months. I w... 17 replies
I will be starting Gilenya in May. I have a 3 month washout period from Tysabri. I will be on Copaxone for 2 months. I w... 17 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.